Thompson E A, Salem H H
J Clin Invest. 1986 Jul;78(1):13-7. doi: 10.1172/JCI112541.
Human thrombomodulin significantly inhibited the rate of prothrombin conversion to thrombin by Factor Xa in the presence of phospholipid or platelets, calcium, and Factor Va. Sodium dodecyl sulfate polyacrylamide gel electrophoresis of 125I-prothrombin activation revealed that thrombomodulin reduced the rate of prothrombin activation but did not alter the cleavage pattern. The inhibition was reversed by the inclusion of a highly specific rabbit antithrombomodulin antibody. If thrombomodulin was replaced by hirudin, the rate of thrombin generation was not decreased excluding the possibility that the inhibition by thrombomodulin was secondary to the binding of small amounts of thrombin formed early in the reaction and the prevention of feedback breakdown of prothrombin by thrombin. The inhibitory activity of thrombomodulin was overcome by increasing the concentration of Factor Xa and specific, saturable binding of thrombomodulin to Factor Xa was demonstrated. These results indicate that thrombomodulin binds to Factor Xa and thereby inhibits the activity of the prothrombinase complex.
在磷脂或血小板、钙和因子Va存在的情况下,人血栓调节蛋白显著抑制因子Xa将凝血酶原转化为凝血酶的速率。对125I-凝血酶原激活物进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳显示,血栓调节蛋白降低了凝血酶原激活的速率,但未改变裂解模式。加入高度特异性的兔抗血栓调节蛋白抗体可逆转这种抑制作用。如果用水蛭素替代血栓调节蛋白,凝血酶生成速率并未降低,排除了血栓调节蛋白的抑制作用是由于反应早期形成的少量凝血酶结合以及阻止凝血酶对凝血酶原的反馈分解的可能性。通过增加因子Xa的浓度可克服血栓调节蛋白的抑制活性,并且证明了血栓调节蛋白与因子Xa存在特异性、可饱和结合。这些结果表明,血栓调节蛋白与因子Xa结合,从而抑制凝血酶原酶复合物的活性。